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INTRODUCTION: CHOICE IN A CONSUMER
SOCIETY
Never before have people been faced with such levels of
choice as now enjoyed by those living in affluent societies.
Increases in technological possibilities and relatively high
levels of disposable income have enabled large numbers of
citizens to exercise choice in a wide variety of areas, from
contraception to managing their infertility, from deciding
where to educate children to which career to follow, which
TV/DVD/computer to buy, where to holiday, etc.
However, when it comes to deciding about death,
choice is a more contentious notion. As the comedian
Woody Allen once said ‘I am not afraid of death, I just
don’t want to be there when it happens.’ While individuals
can influence their health and illness through lifestyle
choices, most have relatively little choice with respect to
the time, manner and place of their death.1 With recent
moves to legalize euthanasia and physician-assisted suicide in
some countries, choice regarding place and time of death
has been extended. However, even where such choice is
available, it tends to be utilized by relatively few people.
Less than four percent of deaths in the Netherlands are
reported to be by euthanasia.2
Although most people say that they would prefer to die
at home, there has been a persistent fall in the proportion of
people doing so. This trend has continued, with only 22%
of cancer deaths in the UK in 2003 occurring there.3 The
reasons for this are undoubtedly complex, involving many
aspects of health-care practice and provision as well as social
changes.4 The trend in falling home death rate has
continued despite the rise in community palliative care
services in the UK over the last 20 years.
In line with the all-pervading choice agenda, health care
professionals are increasingly expected to ascertain a
patient’s choice about preferred place of death, record it
and aim to deliver it. Little is known about how health-care
professionals elicit patients’ preferences and the extent to
which eliciting such views enables them to facilitate their
realization. In this paper we present an overview of the UK
policy context and the published literature on preferred
place of death, and examine key issues which arise for
health-care professionals in exploring preferred place of
death with patients. The purpose is to inform debate about
the role health-care professionals play in helping patients
make this most important of choices, and in enabling their
preferences regarding preferred place of death to be
respected.
CHOICE OF PLACE OF DEATH
With the recent White Paper Building on the best: choice,
responsiveness and equity in the NHS, the UK government’s
agenda of choice across the spectrum of health-care, from
birth to death, was laid out.5 With regard to choice and
dying it proposed, ‘To offer all adult patients nearing the
end of life, regardless of their diagnosis, the same access to
high quality palliative care so that they can choose if they
wish to die at home.’ In addition, through funding the End
of Life Care Programme, the government specifically sought
to implement this policy objective.6 Since April 2006,
within the Quality and Outcomes Framework, additional
payments are payable to GPs for keeping a register of
palliative care patients and meeting regularly to plan care at
which ‘preferred place of care’ for individual patients
should be noted.7
For choice to be meaningful, it must involve at least
two—preferably a range of—available, high quality
options; which in terms of place of death should arguably
include home, hospice, hospital and nursing home. In
addition, enabling patients to die in their place of choosing
depends on health-care providers understanding the
patient’s prognosis, likely mode of death, and the
availability and accessibility of services. They will then be
in a position to assist individual patients and their carers
articulate their preferences so that plans can be made and
reviewed over time, to enable choices to be turned into
realities when the time comes.
PREFERRED PLACE OF DEATH
Between 50 and 90% of patients with cancer, when they
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to die at home.8 Several studies from a variety of
countries have linked patients’ expression of their
preferred place with actual place of death, showing
more patients achieve a home death if they have
expressed a wish to do so.9–12 In addition, patients and
carers agreeing on home as the preferred place of death
has been shown to be a strong predictive factor in
achieving a home death.12
Seventeen factors strongly associated with place of death
have recently been reported by Gomes and Higginson.13
Based on a review of 58 studies, they suggested a
conceptual model for ordering such factors in terms of
illness, personal and environmental issues, also highlighting
the dynamic nature of the model since all factors interact
with each other. Preferred place of death is recognized as
changing throughout the disease trajectory, with some
studies showing that a preference for home death decreases
over time,14,15 whilst home remained the preferred place
given more favourable conditions.15
The pattern of change over time was studied
qualitatively by Thomas et al. in an interview study of
cancer patients and their informal carers. This highlighted
the complexities surrounding the issue of preferred place of
death. Contextual factors that influenced patients’ choice
included extent of social network, perception of carers’
attitudes, symptom management, fear of loss of dignity and
the views of the patient/carers of the care provided by
available hospices, nursing homes, hospitals and community
nursing and social services. Patients’ choices were
characterized by uncertainty. Preferences were rarely
categorical, but were qualified by speculation about the
unpredictability of events.16
Although the same standards of care should be offered
to all patients with end stage illness,17 as is common
with issues relating to end of life care the majority of
studies into preferred place of death have focused on
patients with cancer.8 Available evidence suggests that the
preferences of patients with other illnesses, and the
factors influencing them, are not dissimilar from those
with cancer. In a qualitative study of elderly patients’
views regarding home as a place of care when dying,
concerns were expressed regarding the quality of care
which could be provided at home, the appropriateness of
their children providing intimate care, and ambivalence
towards having professional carers in the home.18 One
telephone survey of elderly patients who had recently
been admitted to hospital with cardiac failure, chronic
obstructive airways disease or pneumonia found that
approximately equal numbers expressed preferences for
home compared with hospital care.19 In a follow-up
interview study with a selection of these patients, familiar




It has been suggested that enabling people to die in their
preferred place requires greater empowerment of patients
and families, early and continuous risk assessment, and
better training in palliative care for health-care profes-
sionals, including those that work in primary care.9
However, there is very little evidence to inform how this
should best be done. Issues regarding preferred place of
death will often be discussed along with other concerns of
the patient, including questions regarding likely prognosis
and mode of death. The difficulty in predicting prognosis
and mode of death may confound such discussion. The very
concept of a terminal phase with non-cancer patients is
problematic with, for example, patients with end stage
heart failure or chronic obstructive airways disease tending
to follow a trajectory of steady decline with episodes of
acute deterioration and recovery, rather than the
relatively rapid decline as tends to occur for cancer
patients with advanced metastatic disease (Box 1).20
Whilst determining prognosis for cancer patients is
problematic, with a tendency for overestimation of
survival,21 clinical prediction criteria for prognosis in
patients with end stage non-cancer diagnosis have been
shown to be ineffective;22 in addition, one study showed
that primary care physicians tended to over-estimate the
likelihood of death at one year in patients with end stage
heart failure.23
Each individual patient’s expectations of the dying
process and the way that this shapes their wishes is unique.
Helping patients to identify and articulate their preferences,
and how these evolve in response to the patient’s changing
condition, requires well-developed communication skills,
including considerable sensitivity to differences in values.
Such discussions can only take place effectively within the
context of an ongoing and trusting patient-clinician
relationship, and may require a considerable investment
of time.25
The extent to which patients wish to discuss their
preferred place of death varies from individual to individual.
While some will have openly acknowledged that they are
dying, may be clear of their wish and will articulate clearly
their preferred place of death without being prompted,
others will be in denial regarding their terminal illness,
using this as a protective mechanism; the subject of where
they wish to die may be off limits. Still other patients—
possibly the majority—will be ambivalent. They may not
voice their concerns or wishes openly but may be ready to
discuss the issue if sensitively broached. They may be clear
of what they would want in optimal circumstances, but may
recognize that circumstances as they approach the time of
dying may not favour this and that an alternative place of
death might occur.212
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The patient’s and carer’s wishes may vary with time and
within different contexts, including the extent to which
active treatment is still felt to be an option. For example, a
patient may become fearful of being at home because of a
lack of support, or symptoms may arise which might be
more easily managed as an inpatient. Preferred place of
death should therefore be seen as a dynamic issue within
which the patient’s wishes fluctuate over time. With all of
the contingent issues, the outcome of discussions of
preferred place of death may not be a definitive answer
of ‘home’ or ‘hospice’, but might, as Thomas et al. suggest,
reveal ‘a stronger or weaker leaning in one direction.’16
ADVANCE CARE PLANNING26
Knowledge of preferences will aid advance care planning for
both cancer27 and non cancer patients17,28 and should help
to avoid inappropriate management, particularly hospital
admission, at the end of life (Box 2). Informing secondary
care providers of a patient’s wish to die at home can enable
forward planning so that discharge can be arranged at short
notice if necessary. However, the imminence of death is
often difficult to recognize, and problems with estimating
prognosis may have the consequence that hospital admission
(e.g. for symptom control), although intended to be short-
term, will result in the patient not being discharged. This
may be especially problematic in non-cancer diagnoses,
where prognosis is even more difficult to predict. While
further research may enable new models which improve
accuracy of prediction for both cancer and non-cancer
diseases to emerge,29,30 given the non-linear complexity of
terminal illness, the precision of such models will always
have its limitations.31
EFFECTS ON THE HEALTH-CARE
PROFESSIONAL
Little is known about the effect on health-care professionals
of discussing preferred place of death. The process may
stimulate negative emotions, with concerns that the patient
will react emotionally to the subject being broached. They
may have personal fears regarding discussing such a difficult
and emotive subject openly, including uncertainty about
how best to handle the patient’s and carer’s feelings, or
worries about being asked to make assurances which they
may not be able to fulfil. They may have concerns about
mortality for themselves or their family and friends, or they
may have unresolved grief from past bereavements which
makes the subject of death particularly difficult to discuss.
Personal knowledge of the patient over time may help to
prepare the professional and the patient for discussion of the
issue, but conversely it may also make the issue more
difficult to discuss openly if an emotional tie has developed
between them. Professionals with a close relationship with
patients may tend to overestimate prognosis and fail to
recognize the impending onset of the terminal phase.32
The health-care professional may feel it particularly
difficult to discuss preferred place of death with a patient
when providing adequate community services or securing
admission to a hospice may not be possible. Preferred place
of death may be a hollow concept and the promise of choice
a cruel sham if services are not available because of lack of
funding or other resources. Whilst simplistic rhetoric
promising patients a planned death is seductive, the reality
may be that the complex uncontrollable nature of the dying
process exposes real choice as being fool’s gold.
CONCLUSION
In this paper, we have summarized issues that influence
choice and preferred place of death. Ascertaining a patient’s 213
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Box 1 Illness trajectories at the end of life24
Three end of life illness trajectories have been described,
although in practice there is often much overlap between
them for individual patients, and death can occur at any
point along the course of the illness.20
(1) Long period of chronic illness and short period of
terminal decline
. Typically occurs in cancer;
. The onset of terminal decline may be relatively clear, although
length of the process is difficult to predict;
. Even within the terminal phase, there may be periods of
improvement and deterioration with high degrees of individual
variation.
(2) Gradual functional deterioration punctuated by
episodes of serious acute illness
. Typically occurs with advanced cardio-respiratory disease;
. Functional impairment secondary to reduction in cardio-
respiratory performance is relentless, often over several
years;
. Acute exacerbations of heart failure or acute on chronic
respiratory failure punctuate this course, each one of which is
potentially fatal, although typically several occur before the
final attack ensues;
. Functional impairment following exacerbations is frequently
marked;
. Patients in this group often have co-morbid conditions.
(3) ‘Prolonged dwindling’ of the very elderly
. Often seen in residents of care homes for the elderly;
. Patients frequently have multiple degenerative disorders,
including cognitive impairment resulting from various forms
of dementia;
. The patient suffers poor health and low levels of functioning
over a prolonged period of time, sometimes several years;
. The terminal event may be the result of an acute problem,
such as chest infection or fractured neck of femur, or may be
harder to define in terms of medical causation.
wishes with regard to place of death is an important
function in end of life care, and should be approached
sensitively and regularly reviewed as the patient approaches
death, within a realistic evaluation of the feasibility of
different options. Discussions will need to involve the
patient’s family and/or other informal carers. Preferences
when clarified can aid in advance care planning to enable
patients to achieve their goals; however, the complexities
surrounding clinical course and limited resources are likely
to confound patients’ plans even with health-care services of
the highest standard.
Since the issue is difficult to discuss, a professional with
an established relationship with the patient—such as the GP
or district nurse—is arguably the most appropriate person
to perform the task, using a sensitive approach, well
developed communication skills and providing ongoing
relational continuity. Whilst clearly recording the patient’s
preference in the health-care record is important, it must
not become a mechanical ‘tick box’ exercise. The recent
change to the Quality and Outcomes Framework in the UK
has introduced a financial incentive for practitioners to
record patients’ preferred place of death. While this may
encourage more patient-centred end of life-care, perversely
it could lead to a more perfunctory approach. Investigating
the experiences of health-care professionals in this difficult
and sensitive task is an important area for further research.214
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Case 1: Mr A, a 76-year-old ex-lorry driver with NYHA stage IV heart failure, diabetes, painful neuropathy of his lower legs and
gout in his feet.
Mr A is housebound and cared for by his 69-year-old wife, who is in reasonable health. He has had several admissions to hospital with acute
left ventricular failure (LVF) over the last two years, which he always finds distressing. He discusses future management with his cardiac
failure nurse on one of her regular visits, when he says he has ‘had enough.’ They explore alternatives to hospital admission for any further
episode of acute LVF, and Mr A agrees to a multidisciplinary discussion of plans for managing him at home if at all possible. This discussion
takes place at the next primary care team meeting between the GP and district nurse which the cardiac failure and Macmillan nurse attend.
A plan is drawn up for Mr A to have subcutaneous diamorphine via a syringe driver and furosemide as required at home if and when further
LVF occurs. The cardiac failure nurse checks the appropriate dose of furosemide with his cardiologist and the Macmillan nurse and GP
decide on the appropriate dose of diamorphine. A prescription for the agreed drugs is written so that anticipatory medication can be kept in
his home. Instructions are written in the district nursing notes kept in his home and faxed to the out-of-hours primary care provider.
Six weeks later Mr A suffers breathlessness and acute chest pain on a Sunday afternoon. He is visited by the on-call GP who gives him
intravenous furosemide and arranges for the district nurse to commence the diamorphine driver.
All has gone to plan but the outcome is still not certain. The following two scenarios are amongst several possibilities:
Scenario A: Mr A’s pain is controlled and his breathlessness improves. Mr A becomes unconscious in the evening and dies the early hours of
the next morning, surrounded by his family.
Scenario B: With controlled pain and improved breathlessness, Mr A remains bed-bound for several days, but with review by the cardiac
failure nurse who receives telephone advice from the cardiologist. His ACE inhibitor dose is adjusted and he recovers to the level of his
previous functioning, though he remains frustrated at his poor quality of life.
Case 2: Mr B, a 63 year old retired headmaster with lung cancer
Mr B has discussed his wish to die at home with his GP since early after his diagnosis with advanced disease six months ago. He has had two
admissions with shortness of breath, for which he has had a right pleural tap and a transfusion on one occasion. He has been increasingly
short of breath for a week and the district nurse takes blood for a full blood count. His haemoglobin is 7.6. His GP visits and discovers that he
also has reduced air entry in his right lung base. They discuss the situation and Mr B agrees that he should be admitted onto the oncology
ward for a transfusion and possible pleural tap. On admission an ultrasound scan of his chest reveals mostly solid tumour with a small amount
of loculated fluid in his right chest. Transfusion is arranged for three units of blood.
Despite transfusion the breathlessness increases and Mr B becomes quite distressed. He is using continuous oxygen, and a syringe driver
with diamorphine and midazolam sedation is commenced. He settles to some extent but is quite drowsy and confused. His wife and family
feel that they could not cope even with additional support at home and request that he remains in hospital. Mr B is too confused and drowsy
to enter into discussions. He dies in hospital after a further 48 hours.
The Macmillan nurse spends time with Mrs B exploring her feelings with regard to her husband’s wishes for a home death not being met. She
is upset and feels that she has failed him. Several meetings are needed to support Mrs B.
Finally she accepts the inevitability of the hospital death, but still feels sad that her husband did not die at home as he had hoped.
Box 2 Advance care planning around preferred place of death
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